본문 바로가기

Endovascular treatment of the vertebral artery origin stenosis by using the closed-cell, self-expandable Carotid Wallstent

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q4Scopus Q3
저널
INTERVENTIONAL NEURORADIOLOGY26(6) · pp.805 · 2020
피인용
Web of Science 4Scopus 7
FWCI (Scopus)
0
JCR IF
JCR 2019 1.479
ISSN
1591-0199

저자

  1. 고준경제1저자Department of Neurosurgery, Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea
  2. 최창화Department of Neurosurgery, Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea
  3. 황보리Department of Diagnostic Radiology, Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea
  4. 서희붐Department of Diagnostic Radiology, Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea
  5. 이태홍Department of Diagnostic Radiology, Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea
  6. 조한진Department of Neurology, Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea
  7. 성상민교신저자Department of Neurology, Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea

초록

Background Endovascular treatment has been considered a good alternative to surgery for symptomatic vertebral artery origin stenosis (VAOS) due to the high risk of morbidity associated with surgery. The purpose of this study was to evaluate the feasibility and efficacy of insertion of the closed-cell, self-expandable Carotid Wallstent for the treatment of VAOS. Methods The records of 72 patients with VAOS refractory to adequate medication who were treated by endovascular treatment with the Carotid Wallstent from December 2006 to November 2018 were retrospectively evaluated. Results Of the 72 patients, 43 presented with transient ischemic attacks. Forty-seven patients (65.3%) manifested other brachiocephalic stenoses; of these, 40 patients had occlusion, hypoplasia, or stenosis of the contralateral vertebral artery. Overall technical success (defined as 20% or less residual stenosis) was 100%. Procedure-related complications (n = 8, 11.1%) included sudden asystole (n = 1), acute in-stent thrombosis (n = 3), minor stroke (n = 3), and stent shortening (n = 1). All complications were resolved without permanent neurological deficit. Angiographic follow-up (mean, 13.0 months) was achieved in 49 patients and revealed in-stent restenosis in 1 patient (2.0%) and stent malposition by shortening in 2 patients (4.1%). Follow-up records were available in 57 patients (mean 15.6 months). Three of the 57 patients (n = 3, 5.3%) had recurrent symptoms of vertebrobasilar ischemia and none was retreated. Conclusions Endovascular treatment of symptomatic VAOS using the closed-cell, self-expandable Carotid Wallstent is technically feasible and effective in alleviating patient symptoms and for improving vertebrobasilar blood flow.

키워드

Stentvertebral arteryvertebrobasilar insufficiencyDRUG-ELUTING STENTANGIOPLASTYRESTENOSISPROTECTIONPLACEMENTFRACTUREDISEASEDEVICERISK

식별자

Scopus EID
2-s2.0-85086736135
WoS UID
000542266800001